EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 105 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $147 | -46.4% | 26,390 | -49.7% | 0.00% | -100.0% |
| Q1 2024 | $274 | -81.7% | 52,446 | -81.8% | 0.00% | -83.3% |
| Q4 2023 | $1,501 | -59.8% | 287,555 | +21.4% | 0.01% | -62.5% |
| Q3 2023 | $3,733 | -14.4% | 236,902 | +5.5% | 0.02% | -11.1% |
| Q2 2023 | $4,361 | -28.6% | 224,576 | +4.2% | 0.02% | -33.3% |
| Q1 2023 | $6,108 | -9.7% | 215,431 | -7.0% | 0.03% | -18.2% |
| Q4 2022 | $6,765 | -99.9% | 231,587 | -25.6% | 0.03% | -26.7% |
| Q3 2022 | $8,223,000 | -1.0% | 311,220 | +66.5% | 0.04% | +7.1% |
| Q2 2022 | $8,303,000 | +20.2% | 186,873 | +33.8% | 0.04% | +50.0% |
| Q1 2022 | $6,908,000 | +28.2% | 139,695 | +31.9% | 0.03% | +40.0% |
| Q4 2021 | $5,388,000 | -25.3% | 105,879 | -18.2% | 0.02% | -28.6% |
| Q3 2021 | $7,213,000 | -35.6% | 129,430 | -50.5% | 0.03% | -33.3% |
| Q2 2021 | $11,200,000 | +26.0% | 261,703 | +22.9% | 0.04% | +20.0% |
| Q1 2021 | $8,890,000 | +11.3% | 213,009 | +24.2% | 0.04% | +12.9% |
| Q4 2020 | $7,988,000 | +11.5% | 171,484 | +1.7% | 0.03% | +3.3% |
| Q3 2020 | $7,167,000 | +26.5% | 168,699 | +42.9% | 0.03% | +25.0% |
| Q2 2020 | $5,664,000 | +39.9% | 118,056 | +34.1% | 0.02% | +4.3% |
| Q1 2020 | $4,049,000 | +185.5% | 88,013 | +272.9% | 0.02% | +283.3% |
| Q4 2019 | $1,418,000 | -17.8% | 23,600 | -22.6% | 0.01% | -14.3% |
| Q3 2019 | $1,725,000 | -11.1% | 30,493 | -12.6% | 0.01% | -22.2% |
| Q2 2019 | $1,941,000 | +824.3% | 34,873 | +740.7% | 0.01% | +800.0% |
| Q1 2019 | $210,000 | +73.6% | 4,148 | +37.9% | 0.00% | 0.0% |
| Q4 2018 | $121,000 | +5.2% | 3,008 | +82.1% | 0.00% | – |
| Q3 2018 | $115,000 | -42.8% | 1,652 | -56.1% | 0.00% | -100.0% |
| Q4 2017 | $201,000 | -55.9% | 3,761 | -50.8% | 0.00% | -50.0% |
| Q3 2017 | $456,000 | – | 7,637 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |